94.48
전일 마감가:
$94.06
열려 있는:
$93.38
하루 거래량:
203.42K
Relative Volume:
0.43
시가총액:
$2.05B
수익:
$747.40M
순이익/손실:
$-12.60M
주가수익비율:
-122.91
EPS:
-0.7687
순현금흐름:
$105.18M
1주 성능:
+1.28%
1개월 성능:
+5.40%
6개월 성능:
+29.51%
1년 성능:
+68.68%
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
명칭
Ani Pharmaceuticals Inc
전화
(218) 634-3500
주소
210 MAIN STREET WEST, BAUDETTE, MN
ANIP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ANIP
Ani Pharmaceuticals Inc
|
94.48 | 2.10B | 747.40M | -12.60M | 105.18M | -0.7687 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.63B | 260.53M | 4.77B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 개시 | H.C. Wainwright | Buy |
| 2025-03-14 | 개시 | Jefferies | Buy |
| 2025-03-12 | 개시 | JP Morgan | Overweight |
| 2024-12-11 | 개시 | Leerink Partners | Outperform |
| 2024-10-11 | 개시 | Piper Sandler | Overweight |
| 2024-03-15 | 개시 | CapitalOne | Overweight |
| 2023-08-22 | 재확인 | H.C. Wainwright | Buy |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2022-09-07 | 개시 | H.C. Wainwright | Buy |
| 2021-11-02 | 개시 | Truist | Buy |
| 2020-05-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-05-10 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | 재확인 | Canaccord Genuity | Buy |
| 2017-07-31 | 개시 | Canaccord Genuity | Buy |
| 2017-02-22 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2016-06-23 | 개시 | Raymond James | Strong Buy |
| 2016-05-24 | 다운그레이드 | Standpoint Research | Buy → Hold |
| 2015-11-13 | 개시 | Standpoint Research | Buy |
| 2015-09-28 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2015-08-05 | 재확인 | Oppenheimer | Outperform |
| 2015-08-04 | 재확인 | ROTH Capital | Neutral |
| 2015-07-31 | 재확인 | Oppenheimer | Outperform |
| 2015-07-15 | 재확인 | ROTH Capital | Neutral |
| 2015-06-23 | 재확인 | Oppenheimer | Outperform |
| 2015-05-18 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 재확인 | Oppenheimer | Outperform |
| 2015-04-10 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2015-02-26 | 재확인 | ROTH Capital | Buy |
| 2015-02-18 | 재확인 | Oppenheimer | Outperform |
모두보기
Ani Pharmaceuticals Inc 주식(ANIP)의 최신 뉴스
What high frequency data says about ANI Pharmaceuticals Inc.Analyst Downgrade & Consistent Profit Trade Alerts - newser.com
What insider trading reveals about ANI Pharmaceuticals Inc. stockWeekly Stock Summary & Proven Capital Preservation Methods - newser.com
How ANI Pharmaceuticals Inc. stock trades during market volatilityTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Can ANI Pharmaceuticals Inc. stock continue upward trendJuly 2025 Momentum & Entry and Exit Point Strategies - newser.com
Smart tools for monitoring ANI Pharmaceuticals Inc.’s price actionWeekly Trend Summary & Fast Entry High Yield Stock Tips - newser.com
Why ANI Pharmaceuticals Inc. (BSFA) stock is a strong buy callGlobal Markets & Detailed Earnings Play Alerts - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock boost dividends further2025 Pullback Review & Long Hold Capital Preservation Tips - newser.com
Using flow based indicators on ANI Pharmaceuticals Inc.2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
ANI Pharmaceuticals (ANIP): Evaluating Valuation After Strong 2024 Share Price Gains - Yahoo Finance
Applying Elliott Wave Theory to ANI Pharmaceuticals Inc.Market Risk Report & Real-Time Volume Trigger Notifications - newser.com
Is ANI Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 Summary & Weekly Stock Performance Updates - newser.com
Is ANI Pharmaceuticals Inc. stock cheap at current valuation2025 Risk Factors & Daily Stock Trend Watchlist - newser.com
Predicting ANI Pharmaceuticals Inc. trend using moving averagesQuarterly Risk Review & Technical Entry and Exit Tips - newser.com
What indicators show strength in ANI Pharmaceuticals Inc.Weekly Investment Report & Long-Term Safe Return Strategies - newser.com
ANI Pharmaceuticals (NASDAQ:ANIP) Has A Somewhat Strained Balance Sheet - 富途牛牛
Why ANI Pharmaceuticals Inc. stock could rally in 2025Weekly Stock Summary & Safe Entry Zone Identification - newser.com
Published on: 2025-11-01 04:07:10 - newser.com
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Reversal indicators forming on ANI Pharmaceuticals Inc. stockJuly 2025 Update & Safe Entry Zone Identification - newser.com
Published on: 2025-10-31 04:40:15 - newser.com
Regression analysis insights on ANI Pharmaceuticals Inc. performanceWeekly Market Report & Safe Entry Point Alerts - newser.com
ANI Pharmaceuticals (ANIP) to Release Earnings on Friday - MarketBeat
ANI Pharmaceuticals, Inc. (ANIP) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Teacher Retirement System of Texas - MarketBeat
ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada
ANI Pharma wins Overweight rating at J.P. Morgan on growth prospects - MSN
Mizuho Markets Americas LLC Buys 15,357 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals Inc Stock Analysis and ForecastMarket Rumors and News & Trade Like a Pro Using AI Edge - earlytimes.in
ANI Pharmaceuticals: Strong Buy On Rare Disease Growth, Record Of Beating Estimates - Seeking Alpha
What dividend safety score for ANI Pharmaceuticals Inc. stockTrade Performance Summary & Low Risk High Win Rate Picks - Fundação Cultural do Pará
Will ANI Pharmaceuticals Inc. stock benefit from automationEarnings Growth Report & Weekly High Potential Stock Alerts - fcp.pa.gov.br
Will ANI Pharmaceuticals Inc. stock maintain growth storyJuly 2025 PostEarnings & High Win Rate Trade Tips - Fundação Cultural do Pará
Ani Pharmaceuticals Inc (ANIP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):